BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26196379)

  • 21. Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.
    Chiodi V; Uchigashima M; Beggiato S; Ferrante A; Armida M; Martire A; Potenza RL; Ferraro L; Tanganelli S; Watanabe M; Domenici MR; Popoli P
    Neurobiol Dis; 2012 Mar; 45(3):983-91. PubMed ID: 22207189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
    Di S; Itoga CA; Fisher MO; Solomonow J; Roltsch EA; Gilpin NW; Tasker JG
    J Neurosci; 2016 Aug; 36(32):8461-70. PubMed ID: 27511017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged cannabinoid exposure alters GABA(A) receptor mediated synaptic function in cultured hippocampal neurons.
    Deshpande LS; Blair RE; DeLorenzo RJ
    Exp Neurol; 2011 Jun; 229(2):264-73. PubMed ID: 21324315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission.
    Domenici MR; Azad SC; Marsicano G; Schierloh A; Wotjak CT; Dodt HU; Zieglgänsberger W; Lutz B; Rammes G
    J Neurosci; 2006 May; 26(21):5794-9. PubMed ID: 16723537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.
    Katona I; Sperlágh B; Sík A; Käfalvi A; Vizi ES; Mackie K; Freund TF
    J Neurosci; 1999 Jun; 19(11):4544-58. PubMed ID: 10341254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoid modulation of cortical up-states and NREM sleep.
    Pava MJ; den Hartog CR; Blanco-Centurion C; Shiromani PJ; Woodward JJ
    PLoS One; 2014; 9(2):e88672. PubMed ID: 24520411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
    Pfitzer T; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid Signaling Selectively Modulates GABAergic Inhibitory Input to OFF Bipolar Cells in Rat Retina.
    Vielma AH; Tapia F; Alcaino A; Fuenzalida M; Schmachtenberg O; Chávez AE
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):3. PubMed ID: 32150246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release.
    Földy C; Neu A; Jones MV; Soltesz I
    J Neurosci; 2006 Feb; 26(5):1465-9. PubMed ID: 16452670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.
    Kushmerick C; Price GD; Taschenberger H; Puente N; Renden R; Wadiche JI; Duvoisin RM; Grandes P; von Gersdorff H
    J Neurosci; 2004 Jun; 24(26):5955-65. PubMed ID: 15229243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.
    Sperlágh B; Windisch K; Andó RD; Sylvester Vizi E
    Neurochem Int; 2009 Jun; 54(7):452-7. PubMed ID: 19428788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GABAergic and cortical and subcortical glutamatergic axon terminals contain CB1 cannabinoid receptors in the ventromedial nucleus of the hypothalamus.
    Reguero L; Puente N; Elezgarai I; Mendizabal-Zubiaga J; Canduela MJ; Buceta I; Ramos A; Suárez J; Rodríguez de Fonseca F; Marsicano G; Grandes P
    PLoS One; 2011; 6(10):e26167. PubMed ID: 22022550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CB1 receptors diminish both Ca(2+) influx and glutamate release through two different mechanisms active in distinct populations of cerebrocortical nerve terminals.
    Godino Mdel C; Torres M; Sánchez-Prieto J
    J Neurochem; 2007 Jun; 101(6):1471-82. PubMed ID: 17286592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic Protein Synthesis Is Required for Long-Term Plasticity of GABA Release.
    Younts TJ; Monday HR; Dudok B; Klein ME; Jordan BA; Katona I; Castillo PE
    Neuron; 2016 Oct; 92(2):479-492. PubMed ID: 27764673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.
    Daniel H; Rancillac A; Crepel F
    J Physiol; 2004 May; 557(Pt 1):159-74. PubMed ID: 15034129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing.
    Oliet SH; Baimoukhametova DV; Piet R; Bains JS
    J Neurosci; 2007 Feb; 27(6):1325-33. PubMed ID: 17287507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
    Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
    Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production.
    Galante M; Diana MA
    J Neurosci; 2004 May; 24(20):4865-74. PubMed ID: 15152047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex.
    Castaldo P; Magi S; Gaetani S; Cassano T; Ferraro L; Antonelli T; Amoroso S; Cuomo V
    Neuropharmacology; 2007 Sep; 53(3):369-78. PubMed ID: 17631920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.